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Abstract: Toscana virus (TOSV) is an arthropod-borne virus which is transmitted to humans by Phlebotomus spp sandflies. 
Infection is the cause of brain injuries, such as aseptic meningitis and meningoencephalitis, in Italy mainly during the 
summer. More recently some unusual clinical manifestations due to TOSV with severe sequelae, such as ischemic 
complications and hydrocephalus, have been reported. TOSV represents an important emerging pathogen and its presence is 
being investigated in several European countries on the Mediterranean basin, including Italy, France, Spain, Portugal and 
Cyprus. Phylogenetic analysis has distinguished two genotypes of TOSV, A and B; the first is circulating mainly in Italy and 
the second in Spain, indicating a different geographic distribution possibly related to the vector. This distribution, evolving 
with the climate, globalization and habitat modification, has implications for the epidemiology of TOSV. 
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INTRODUCTION 
  Toscana Virus (TOSV) belongs to the Phlebovirus genus 
of the Bunyaviridae family, it is an arthropod-borne virus 
transmitted
  to humans by Phlebotomus,  Sergentomyia and 
Lutzomya genera, in particular by Phlebotomus perniciosus 
and P. perfiliewi. The virus can be transmitted transovarially 
in the insect vectors, but its animal reservoir has not been 
identified yet. TOSV isolation from the brain of a bat 
(Pipistrellus kuhli) has been the only evidence of the 
possible involvement of this species in the ecology of the 
virus [1-3]. However, serological investigations have shown 
that anti-TOSV specific IgG has been detected in some 
animal species [4], indicating that this virus can also infect 
animals [4]. Its genome is composed of three negative 
single-strand RNA segments (ssRNA -) designated Large 
(L), Medium (M) and Small (S). The different segments 
code respectively for the RNA-dependent RNA-polymerase 
(L) [5], two envelope glycoproteins (GN and GC) [6, 7] and a 
nucleocapsid protein (N) [8]. Moreover, two non-structural 
proteins (NSm and NSs) are coded by the M and S segments, 
respectively. Among sandfly-transmitted viruses, three 
serotypes have been identified: Naples, Sicilian and Toscana. 
Naples
 and Sicilian serotypes have the widest geographical 
distribution which is related to the distribution of the vector 
(P. pappatasi) and they have been isolated from sandflies in 
Africa, central Asia, the Americas and Europe. In temperate 
regions, peak sandfly activity occurs during summer when 
the human population in these areas is exposed to sand-fly 
transmitted diseases, including those caused by 
phleboviruses, as demonstrated by serological investigations 
performed on the indigenous populations and tourists 
visiting these areas [9-18]. SSFV and SNFV are aetiologic 
agents of mild,
  self-limited disease characterized by fever,  
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myalgia, and headache [19, 20]. However, TOSV is the 
major cause of aseptic meningitis (95%) and meningoence-
phalitis (4.5%) and influenza-like illness during the summer 
season [21, 22]. Most cases of the disease have been reported 
in residents or travelers in central Italy or Spain, but a 
growing number of cases has been recorded in other 
countries in the Mediterranean basin, including Portugal, 
France, Cyprus, Turkey and Greece [23-27]. Asymptomatic 
infection and infection without central nervous system 
involvement due to TOSV, such as febrile erythema or 
influenza-like illness, have also been described [21, 28]. 
Unusual clinical manifestations or severe sequelae, such as 
hydrocephalus, epididimo-orchitis and ischemic compli-
cations, have recently been reported [21, 22, 28-30]. Genome 
sequence information is now available for evaluating its 
geographical distribution, virus surveillance and studying 
emerging pathogens [10]. In the past few years, some 
scientific studies have focused on the genetic analysis and 
phylogenetic relationship between the TOSV strains that 
have been isolated in different European countries [31-34]. 
Two different clusters of TOSV, genotypes A and B, were 
clearly distinguished and the geographic distribution may be 
different for each TOS virus genotype [31]. Reinfection 
cases have not been detected so far and preexisting immunity 
plays a role in limiting disease in the affected areas of 
current TOSV prevalence. However, this virus could be a 
threat to human health, in particular for populations outside 
the considered area, thus research and surveillance studies 
should be promoted to prevent its spread in new areas. 
TOSCANA VIRUS IN ITALY 
  Toscana virus was isolated for the first time in 1971 from 
P. perniciosus in Monte Argentario (Grosseto, Tuscany) [1, 
35, 36], but it was recognized as a causative agent of 
neurological disease in humans only in 1983, when it was 
isolated for the first time from a young woman with 
lymphocytic meningitis [37]. A serosurvey for the presence 
of antibodies to Sicilian sandfly virus, Naples sandfly virus 
and Toscana virus highlighted that in spite of the use of Toscana Virus Epidemiology: From Italy to Beyond  The Open Virology Journal, 2010, Volume 4    23 
insecticide-spraying malaria eradication campaigns in Italy 
after 1940, Toscana virus was still observed annually in 
central Italy during summer, causing meningitis or 
meningoencephalitis [19, 20, 38, 39]. The rate of TOSV-
associated meningitis during summer in Italy was 
demonstrated by an epidemiological study conducted on 
hospitalized patients residing in Tuscany during the 1995-
1998 period. About eighty percent of cases of aseptic 
meningitis were due to TOSV infection [38]. The incisive 
role of TOSV as an etiologic agent of neurological diseases 
in central Italy was clearly underlined by Pauri P. in a study 
conducted from 1999 through 2003 (personal communi-
cation). Further serological analyses were conducted on a 
high-risk population occupationally exposed to viral 
infection in two regions of Italy: Tuscany and Piedmont. The 
results indicated a TOSV seroprevalence of 77.2% in 
forestry workers, particularly in Tuscany, compared to 
22.7% of seropositivity in the urban population (Table 1). 
This finding is strictly correlated with the favorable habitat 
for the arthropod vectors in the regions where the specific 
vector lives [40]. Moreover, this serological analysis 
underlined the presence of asymptomatic infections of 
TOSV in exposed people. Another serological investigation 
 
Table  1.  Prevalence of TOSV Antibodies in Occupationally 
Exposed and Citizens of Two Italian Regions [40] 
 
No. (%) Tested for TOSV Antibodies 
Population 
Positive Negative  Total 
Tuscany 
Forestry workers  278 (77.2)  82 (22.8)  360 
Control  66 (22.7)  224 (77.3)  290 
Piedmont 
Forestry workers  3
a (6)  47 (94)  50 
Control  1 (2.5)  39 (97.5)  40 
aTwo sera with borderline value. 
 
carried out on asymptomatic household contacts of central 
nervous system infection patients showed anti-TOS IgG 
seropositivity in 22% and IgG/IgM seropositivity in 6% of 
the subjects [20, 41]. These data confirm that TOSV 
infection can occur in humans with mild or even no 
symptoms. A more recent and wider study carried out in the 
Siena area during the years of 1993-2008 showed that a high 
rate of meningitis in the summer is due to TOSV infection 
(399 cases), with a peak in 2005 and 2006 (Fig. 1A) [42]. A 
significant decrease in cases was recorded in 2007-2008. A 
retrospective analysis of the climate in this area, during the 
summer of 2006, revealed that the temperature was 3-5 °C 
higher than 2007, with more days at extremely higher 
temperatures compared to the seasonal mean values. The 
incidence of TOSV aseptic meningitis in central Italy was 
higher in July, August and September (Fig. 1B). Some 
sporadic TOSV activity was noted during the remaining span 
of time. Other reports of TOSV infections have been 
described in northern Italy (Emilia Romagna, Piedmont) [28, 
40, 43] and in other regions, including the Marches, Umbria, 
Lazio, Campania and Sardinia [44-46]. In this context, two 
cases of meningoencephalitis with severe sequelae, such as 
hydrocephalus caused by TOSV, were observed in Umbria 
[29]. A recent retrospective study on the antibody prevalence 
rates of Toscana virus (TOSV) among children and adults 
was performed in a population (n=2737) living in Tuscany 
during 1999-2006 [47]. The seroprevalence rate was 19.8% 
in adults and 5.8% in children, showing an age-dependent 
increase in TOSV specific immunity. Moreover, correlating 
seroprevalence to the clinical profile, the study indicated that 
asymptomatic TOSV infection is more frequent in young 
people (91%) than in adults (31.4%), in whom a higher 
incidence of severe signs of neurological disorders correlated 
to TOSV infection are present (Fig. 2). It is still unclear why 
this occurs. 
TOSCANA VIRUS IN THE IBERIAN PENINSULA 
  Several clinical manifestations of TOSV infection have also 
been reported in Spain and Portugal. In Portugal, a retrospective 
study performed on cerebrospinal fluid samples from patients 
with a diagnosis of meningitis collected between May and 
September from 2002 through 2005 revealed the presence of 
TOSV in 5.6% patients, as a causative agent of neurological 
disease in Portuguese inhabitants [24]. A large epidemiological 
study conducted in the province of Granada by a Spanish group 
[25] established TOSV as one of the most important etiological 
agents of CNS diseases. The seropoprevalence rate for TOSV 
was 24.9%, as also observed in Italy [48], while other 
seroprevalence studies carried out in northern Europe [49] 
report a lower rate, confirming that TOSV is endemic in the 
Mediterranean area. The high seroprevalence rates suggest that 
diagnosis is frequently missed since most cases are mild and a 
severe pathology appears in only a few subjects. A possible 
explanation could be that the TOSV circulating in this region is 
less neurovirulent than the Italian one, but this has been refuted 
by some case reports describing serious clinical manifestations 
in TOSV infected patients. Two unusual severe neurological 
sequelae were reported, and in both cases TOSV diagnosis was 
carried out by RT-PCR and serological methods. 
Immunoglobulins M were detected at a very late stage of 
infection, while a borderline level of IgG was found several 
months after admission. Both patients reported ischemic 
complications and the outcome of the infection was probably 
influenced by their compromised immune systems [22]. A case 
of deafness after TOSV meningitis has also recently been 
described [30]. In any case, the seasonal distribution, between 
June and October with a peak of incidence in August (53%), the 
age dependency of TOSV infection and the predominance of 
disease in rural area residents (11.64%) are similar to those 
recorded in Italy [50, 51]. In 2003, the Spanish Ministry of 
Health sponsored “EVITAR” (Enfermedades Viricas 
Transmitidas por Artropodos y Roederes), a network for the 
surveillance of arthropod- and rodent-transmitted viruses. As a 
part of this study, a broad serological and molecular 
investigation on TOSV was performed [25]. TOSV was also 
isolated from sandfly pools captured in the Granada province 
and its genome was sequenced, providing genetic information 
for a better characterization of TOSV strains circulating in 
Spain. 
TOSCANA VIRUS IN FRANCE 
  Toscana virus distribution is not restricted to Italy and 
Spain, as other European countries are also  affected.  During  24    The Open Virology Journal, 2010, Volume 4  Cusi et al. 
 
Fig. (1). (A) Toscana virus meningitis in the Siena area during the years 1993-2008. (B) Seasonal distribution of TOSV meningitis in 
Tuscany. 
 
Fig. (2). Clinical manifestation of TOSV infection in seropositive subjects. Asymptomatic infection (white) is more frequent in young people 
(A) than in adults (B) [47]. 
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a program of surveillance for West Nile virus in southern 
France, several samples with suspected meningitis were also 
tested for the presence of TOSV [26] and some resulted 
positive by molecular and serological techniques. The virus 
was then isolated on cell cultures from clinical samples and 
from arthropod vectors, indicating that it was circulating in 
southern France and could cause neurological disease in 
some subjects [33]. To date, two native cases of TOSV 
infections have been reported in the south of France [21]. So 
far only one case of TOSV infection has been described in a 
German traveler returning from France [11]. Recently the 
first imported case of meningoencephalitis due to TOSV in a 
traveler returning from Italy to France was reported [18]. An 
interesting study on seroprevalence was conducted in 
volunteer blood donors in France, showing that 12 % of sera 
from healthy donors and 18.9% of sera from patients 
hospitalized for CNS infection were IgG positive for TOSV, 
confirming that TOSV circulates in southeastern France and 
that a significant proportion of healthy blood donors have a 
history of TOSV infection [52]. These data raise concerns 
about potential implications for blood donors and the risk of 
transmitting the virus to naïve subjects. 
TOSV IN THE REST OF EUROPE 
  Other countries in the Mediterranean basin are affected 
by the presence of sandflies and, consequently, arthropod-
borne phleboviruses. Some sporadic seroprevalence 
investigations performed in Greece, Cyprus, Israel, Tunisia, 
Algeria and even Iran, have shown that the naïve population 
can be infected by Phleboviruses consisting of many 
serotypes [27, 53-56]. Most of these studies have recorded 
the presence of anti SSFV antibodies, but it is likely that a 
specific antibody response against TOSV could also be 
found. The presence of sandfly fever virus was also 
investigated in Bosnia and Herzegovina in a serological 
study of the local population. The presence of specific anti-
TOSV antibodies was revealed in a group of patients during 
2006-2008 [16]. Since this region also appears to be affected 
by the virus, further serological analysis are needed for 
evaluating the presence of TOSV in this wide area, in order 
to adopt measures of prevention of the disease. The 
circulation of endemic viruses has been facilitated through 
globalization, and TOSV is a good example. In fact, TOSV 
infections have been reported in people visiting endemic 
areas (Fig. 3). The first well described case concerns 
Swedish soldiers based in Cyprus during 1985: twenty 
percent showed seroconversion to TOSV with specific IgG 
without any signs of illness [14]. In light of these data, a 
retrospective investigation was conducted by Eitrem et al. on 
Swedish tourists that had visited the region for the presence 
of Toscana virus in Cyprus [57]. All three serotypes of the 
sandfly fever viruses (Sicilian, Naples and Toscana) were 
detected in Cyprus, with a higher incidence of Sicilian and 
Naples strains than Toscana (antibody prevalence rates 32% 
and 57%, respectively) [23]. Other scientists have focused 
their attention on this emerging virus in order to diagnose 
some forms of meningitis, particularly those affecting people 
who had visited endemic areas in the summer. In fact, 
several cases of aseptic meningitis in tourists returning from 
Italy, Spain or France were related to TOSV. Some 
infections imported into Germany by people returning from a 
vacation in Tuscany, France, Spain or Portugal have been 
reported [11, 12, 49, 58-61]. Another case of imported 
TOSV infection has been recorded in the Netherlands, where 
a patient with meningoencephalitis was hospitalized after a 
vacation in central Italy during the summer [62]. Other 
imported Toscana virus infections acquired by travelers have 
been reported during the past few years. In Switzerland, a 
case of meningitis due to TOSV infection was reported in a 
tourist who had stayed on the coast of Tuscany (Elba Island) 
during August [63]. On the basis of these data, Toscana virus 
meningitis should be included in the differential diagnosis of 
people with neurological symptoms returning from a holiday 
in the Mediterranean area. 
PHYLOGENETIC ANALYSIS AMONG TOSV ISO-
LATES 
  A number of TOSV strains have been isolated from 
clinical samples and Phlebotomus spp. and their genomes 
have been partially or fully sequenced allowing for a 
phylogenetic analysis among strains circulating in the 
Mediterranean. A comparison was carried out among the 
several nucleotide and aminoacid sequences available in 
GenBank. Few differences were found in a partial sequence 
of the nucleoprotein gene among strains isolated in Italy, 
indicating that at least four different genotypes were 
circulating in the same area [39]. A later and more detailed 
analysis of a portion of the M fragment encoding the GN 
glycoprotein was performed by Venturi et al. on some Italian 
TOSV isolates. Phylogenetic analysis revealed four different 
lineages which did not show a close correspondence between 
viral strains and an area or a year of isolation, or with the 
host species. Finally, no correlation between phylogenetic 
clusters and the clinical presentation of the disease could be 
observed [34]. However, this study did not analyze the GC 
gene, the most variable viral gene encoding the protein, 
which is probably involved in recognition and binding to the 
cell receptor [32]. This analysis revealed a nucleotide 
variability in the M segment among circulating strains of 
TOSV, without correlating any variation in the antigenic 
properties with a more neurovirulent strain. At this aim, 
different TOSV strains from Spain were compared with 
isolates from patients and vectors and the Italian reference 
strain (ISS Phl.3) [25]. Sequencing of the N gene and, 
partially the L gene, of strains isolated from patients and 
from vectors showed complete nucleotide and amino acid 
homology. The differences between TOSV and the Italian 
strain indicated, however, that at least two lineages of TOSV 
are circulating. In order to more fully clarify this finding, a 
phylogenetic analysis of the entire genome of TOSV strains 
was carried out on isolates from Spain and France by Collao 
et al. [31]. Pairwise comparison among the genomes showed 
that the S segment is highly conserved, in particular in the N 
gene, while the NSs coding sequence is more variable. 
Among the L and M genes, the M shows the highest rate of 
mutation. This suggests the presence of two geographically 
distinct TOSV genotypes, A and B. The TOSV A genotype 
includes all the Italian strains and it is also circulating in 
France and Portugal; the TOSV B genotype is circulating in 
Spain, France and Portugal. However, the virus circulation in 
Portugal must still be well clarified [31]. Geographic 
differences in genotype distribution may be related to 
differences in vector distribution. 
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CONCLUSION 
  The study and surveillance of arbovirus infections should 
be considered worldwide, since they may cause emergent 
diseases and may represent an important public health 
problem in the coming years. Globalization and habitat 
modification have introduced new infective agents in 
different areas, and global air travel, deforestation, wars and 
changes in agricultural practices, among other factors, have 
changed our relationship with flora and fauna. Thus, new 
diseases have emerged. It is also very important to know 
how viruses and other pathogens evolve so that we will 
better be able to treat them. TOSV is an interesting example 
of an emergent virus transmitted by sandflies. Detailed 
information of the TOSV reservoir host is needed. Except for 
the data regarding its isolation from Pipistrellus kuhlii, no 
other information is available at this time. A serological 
study performed on some animal species in Tuscany 
revealed that ovines and, in particular, horses can be infected 
by TOSV, apparently, without symptoms [4]. However, 
further studies are necessary for identifying the reservoir 
hosts of this virus that are responsible for maintaining it. 
Recent cases of more serious and unusual clinical 
pathologies due to TOSV in humans have been described 
[21, 22, 28-30], indicating that modification in host or in 
vector, as well as in viral agents, can represent an important 
factor responsible for extending the range of well-known 
arboviruses and the unexpected neurovirulence from a 
“common” pathogen. There is no treatment for TOSV 
infection, but supportive therapy is sometimes necessary in 
patients with neurological disease. Moreover, not only 
European countries but also others where phlebotomines are 
diffused should be alert to TOSV as an emergent cause of 
CNS infections. Only prevention, based on large 
epidemiological studies and research, and the development 
of new vaccines may be useful for controlling this viral 
infection. 
 
Fig. (3). Circulation of Toscana virus in Europe and in other countries. : native cases of TOSV infection; : imported cases of TOSV 
infection;  TOSV seropositivity in the population. 
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